240 related articles for article (PubMed ID: 33619228)
21. Fanconi anemia group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes.
Wu Y; Sommers JA; Suhasini AN; Leonard T; Deakyne JS; Mazin AV; Shin-Ya K; Kitao H; Brosh RM
Blood; 2010 Nov; 116(19):3780-91. PubMed ID: 20639400
[TBL] [Abstract][Full Text] [Related]
22. FancJ (Brip1) loss-of-function allele results in spermatogonial cell depletion during embryogenesis and altered processing of crossover sites during meiotic prophase I in mice.
Sun X; Brieño-Enríquez MA; Cornelius A; Modzelewski AJ; Maley TT; Campbell-Peterson KM; Holloway JK; Cohen PE
Chromosoma; 2016 Jun; 125(2):237-52. PubMed ID: 26490168
[TBL] [Abstract][Full Text] [Related]
23. FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses.
Zhang F; Fan Q; Ren K; Auerbach AD; Andreassen PR
Chromosoma; 2010 Dec; 119(6):637-49. PubMed ID: 20676667
[TBL] [Abstract][Full Text] [Related]
24. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Seal S; Thompson D; Renwick A; Elliott A; Kelly P; Barfoot R; Chagtai T; Jayatilake H; Ahmed M; Spanova K; North B; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
Nat Genet; 2006 Nov; 38(11):1239-41. PubMed ID: 17033622
[TBL] [Abstract][Full Text] [Related]
25. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.
Litman R; Peng M; Jin Z; Zhang F; Zhang J; Powell S; Andreassen PR; Cantor SB
Cancer Cell; 2005 Sep; 8(3):255-65. PubMed ID: 16153896
[TBL] [Abstract][Full Text] [Related]
26. FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein.
Gupta R; Sharma S; Sommers JA; Kenny MK; Cantor SB; Brosh RM
Blood; 2007 Oct; 110(7):2390-8. PubMed ID: 17596542
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
28. Opposing Roles of FANCJ and HLTF Protect Forks and Restrain Replication during Stress.
Peng M; Cong K; Panzarino NJ; Nayak S; Calvo J; Deng B; Zhu LJ; Morocz M; Hegedus L; Haracska L; Cantor SB
Cell Rep; 2018 Sep; 24(12):3251-3261. PubMed ID: 30232006
[TBL] [Abstract][Full Text] [Related]
29. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.
Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M
Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317
[TBL] [Abstract][Full Text] [Related]
30. FANCJ helicase controls the balance between short- and long-tract gene conversions between sister chromatids.
Nath S; Somyajit K; Mishra A; Scully R; Nagaraju G
Nucleic Acids Res; 2017 Sep; 45(15):8886-8900. PubMed ID: 28911102
[TBL] [Abstract][Full Text] [Related]
31. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
[TBL] [Abstract][Full Text] [Related]
32. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
[TBL] [Abstract][Full Text] [Related]
33. Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass.
Xie J; Litman R; Wang S; Peng M; Guillemette S; Rooney T; Cantor SB
Oncogene; 2010 Apr; 29(17):2499-508. PubMed ID: 20173781
[TBL] [Abstract][Full Text] [Related]
34. Helicase-inactivating
Kamal L; Pierce SB; Canavati C; Rayyan AA; Jaraysa T; Lobel O; Lolas S; Norquist BM; Rabie G; Zahdeh F; Levy-Lahad E; King MC; Kanaan MN
Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028645
[TBL] [Abstract][Full Text] [Related]
35. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.
Zou J; Zhang D; Qin G; Chen X; Wang H; Zhang D
Cell Cycle; 2014; 13(23):3685-97. PubMed ID: 25483079
[TBL] [Abstract][Full Text] [Related]
37. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy.
Eelen G; Vanden Bempt I; Verlinden L; Drijkoningen M; Smeets A; Neven P; Christiaens MR; Marchal K; Bouillon R; Verstuyf A
Oncogene; 2008 Jul; 27(30):4233-41. PubMed ID: 18345034
[TBL] [Abstract][Full Text] [Related]
38. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
Kote-Jarai Z; Jugurnauth S; Mulholland S; Leongamornlert DA; Guy M; Edwards S; Tymrakiewitcz M; O'Brien L; Hall A; Wilkinson R; Al Olama AA; Morrison J; Muir K; Neal D; Donovan J; Hamdy F; Easton DF; Eeles R; ;
Br J Cancer; 2009 Jan; 100(2):426-30. PubMed ID: 19127258
[TBL] [Abstract][Full Text] [Related]
39. FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response.
Xie J; Peng M; Guillemette S; Quan S; Maniatis S; Wu Y; Venkatesh A; Shaffer SA; Brosh RM; Cantor SB
PLoS Genet; 2012 Jul; 8(7):e1002786. PubMed ID: 22792074
[TBL] [Abstract][Full Text] [Related]
40. Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase.
Kumaraswamy E; Shiekhattar R
Mol Cell Biol; 2007 Oct; 27(19):6733-41. PubMed ID: 17664283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
